IDT Australia Ltd (ASX: IDT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
IDT Australia Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$42.98 million
P/E Ratio
14.45
Dividend Yield
0.00%
Shares Outstanding
429.84 million
Earnings per share
-0.016
Dividend per share
N/A
Year To Date Return
-6.67%
Earnings Yield
6.92%
Franking
100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
IDT Australia Ltd (ASX: IDT)
Latest News
Share Market News
ASX cannabis shares continue progress despite pandemic
Share Market News
How did ASX cannabis shares perform this reporting season?
Share Market News
Cann Group shares wilt 5% on half year operating loss
Share Gainers
Why these 3 ASX cannabis shares are flying high in 2020
Share Market News
The ASX cannabis share hitting fresh highs in 2020
Share Gainers
Why cannabis company Cann Group is rocketing 25% higher on Tuesday
Share Gainers
Why this ASX cannabis share is rocketing 20% higher today
⏸️ Investing
Why these 4 ASX shares are soaring today
⏸️ Investing
Here's why Mayne Pharma Group Ltd shares are going gangbusters
⏸️ Investing
3 under-researched stocks for your watch list
❮2
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 08 May 2006 | $0.0350 | 100.00% | Interim | 26 May 2006 |
| 30 Sep 2005 | $0.0450 | 100.00% | Final | 21 Oct 2005 |
| 08 Apr 2004 | $0.0300 | 100.00% | Interim | 30 Apr 2004 |
IDT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About IDT Australia Ltd
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services.
IDT Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 20 Dec 2024 | $0.10 | $0.00 | 0.00% | 16,572 | $0.10 | $0.10 | $0.10 |
| 19 Dec 2024 | $0.10 | $0.00 | 0.00% | 3,071 | $0.10 | $0.10 | $0.10 |
| 18 Dec 2024 | $0.10 | $0.00 | 0.00% | 2,000 | $0.10 | $0.10 | $0.10 |
| 17 Dec 2024 | $0.10 | $0.00 | 0.00% | 43,714 | $0.10 | $0.10 | $0.10 |
| 16 Dec 2024 | $0.11 | $0.00 | 0.00% | 455 | $0.10 | $0.11 | $0.10 |
| 12 Dec 2024 | $0.10 | $0.00 | 0.00% | 21,096 | $0.10 | $0.11 | $0.10 |
| 11 Dec 2024 | $0.10 | $0.00 | 0.00% | 69,900 | $0.11 | $0.11 | $0.10 |
| 10 Dec 2024 | $0.10 | $0.00 | 0.00% | 12,540 | $0.10 | $0.10 | $0.10 |
| 09 Dec 2024 | $0.10 | $0.00 | 0.00% | 57,023 | $0.11 | $0.11 | $0.10 |
| 05 Dec 2024 | $0.10 | $0.00 | 0.00% | 61,139 | $0.10 | $0.10 | $0.10 |
| 04 Dec 2024 | $0.10 | $0.00 | 0.00% | 41,400 | $0.10 | $0.10 | $0.10 |
| 03 Dec 2024 | $0.10 | $0.00 | 0.00% | 204,469 | $0.10 | $0.11 | $0.10 |
| 02 Dec 2024 | $0.10 | $0.00 | 0.00% | 27,646 | $0.10 | $0.10 | $0.10 |
| 29 Nov 2024 | $0.11 | $0.00 | 0.00% | 20 | $0.11 | $0.11 | $0.11 |
| 28 Nov 2024 | $0.10 | $0.00 | 0.00% | 10,051 | $0.10 | $0.10 | $0.10 |
| 27 Nov 2024 | $0.10 | $0.00 | 0.00% | 226,814 | $0.10 | $0.10 | $0.10 |
| 26 Nov 2024 | $0.10 | $0.00 | 0.00% | 47,166 | $0.11 | $0.11 | $0.10 |
| 25 Nov 2024 | $0.10 | $0.00 | 0.00% | 164,445 | $0.10 | $0.10 | $0.10 |
| 22 Nov 2024 | $0.10 | $0.00 | 0.00% | 324,485 | $0.11 | $0.11 | $0.10 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 21 Dec 2023 | Geoffrey Sam | Buy | 78,720 | $8,265 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Mark Anthony Simari | Non-Executive Director | Oct 2022 |
Mr Simari has over 15 years of Board experience in a diverse range of organisations. He was involved in Paragon Care becoming one of the independent healthcare suppliers in the Australian and New Zealand Markets, creating a healthcare platform spanning across capital equipment, consumables, devices and service and maintenance. He is also Chair of Risk Committee.
|
| Mr Geoffrey Joseph Sam | Non-Executive Director | Oct 2022 |
Mr Sam is the Co-Founder and Board member of Healthe Care Australia Pty Ltd, a privately owned health care company comprising a portfolio of 18 hospitals. He is also a member of the Risk Committee.
|
| Dr Jane Ryan | Non-Executive Director | Jan 2022 |
Dr Ryan has over 30 years of international experience in the pharmaceutical and biotechnology industries where she has held executive roles in management of research and development programs as well as business development and alliance management. Jane has worked in Australia, the United States and United Kingdom. She is also a member of the Risk Committee.
|
| Mr Mark Andrew Licciardo | Company Secretary | Oct 2022 |
-
|
| Mr Paul Joseph Mcdonald | Chief Executive Officer | Sep 2022 |
-
|
| Dr David Sparling | Joint Company Secretary | Feb 2018 |
-
|
| Ms Ancila Desai | Chief Financial OfficerJoint Company Secretary | Jun 2020 |
-
|
| Paul Joseph Mcdonald | Chief Executive Officer |
-
|
|
| Vasanthakumar | Chief Financial Officer |
-
|
|
| Ancila Desai | Chief Financial OfficerJoint Company Secretary |
-
|
|
| Jim Sosic | Chief Operating Officer |
-
|
|
| Nesci | Commercial & Portfolio Director |
-
|
|
| Mark Andrew Licciardo | Company Secretary |
-
|
|
| Marc Flanders | Director of Commercial and Business Development |
-
|
|
| Paula Coutts | Head of People & Safety |
-
|
|
| David Sparling | Joint Company Secretary |
-
|
|
| Priscilla Thiyageas | Quality Director |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| One Managed Invt Funds Ltd Sandon Capital Inv Ltd A/C | 48,283,127 | 11.43% |
| HSBC Custody Nominees (Australia) Limited | 37,840,996 | 8.96% |
| One Fund Services Ltd Sandon Capital Activist A/C | 29,043,707 | 6.88% |
| UBS nominees Pty Ltd | 23,125,664 | 5.47% |
| Merrill Lynch (Australia) Nominees Pty Limited | 20,566,292 | 4.87% |
| Citicorp Nominees Pty Limited | 13,041,421 | 3.09% |
| Mr Anthony John Huntley | 11,500,000 | 2.72% |
| J P Morgan Nominees Australia Pty Limited | 8,922,969 | 2.11% |
| Keiser Investments Pty Ltd Gann Family Retirement A/C | 7,435,523 | 1.76% |
| Invia Custodian Pty Limited Graeme Leslie Blackman A/C | 6,029,710 | 1.43% |
| Picherit'S Farm Pty Ltd Huntley Super Fund A/C | 6,000,000 | 1.42% |
| Mr Edmond Wing Kin Cheung & Mrs Eliza Siu Ling Cheung Edmond & Eliza S/F A/C | 4,929,147 | 1.17% |
| Buttonwood Nominees Pty Ltd | 4,834,275 | 1.14% |
| Ms Melissa Mary Stephens | 3,666,667 | 0.87% |
| On On For Don Pty Ltd Mac Family A/C | 3,544,445 | 0.84% |
| Rossbow Pty Ltd Andrew Macpherson Tdt A/C | 3,483,334 | 0.82% |
| Invia Custodian Pty Limited Paulene Blackman A/C | 3,457,737 | 0.82% |
| Luton Pty Ltd | 3,238,889 | 0.77% |
| Mr Robert Darius Fraser Fraser Family A/C | 3,004,333 | 0.71% |
| Puntero Pty Ltd | 3,000,000 | 0.71% |
